Histrelin (Supprelin LA)

FDA-approved product existsPeptideGH axis & hormones

Awaiting review, BioHarmony verdict

Not yet scored. Queued for review; until then rely on the status and sources below.

What is Histrelin (Supprelin LA)?

FDA-approved histrelin is marketed as Supprelin LA, a 12-month implant for children with central precocious puberty.

Saved on this device only.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

Approved labelSUPPRELIN LA prescribing information for central precocious puberty
PopulationPediatric patients covered by the approved SUPPRELIN LA indication
DoseOne 50 mg implant releasing approximately 65 mcg daily
RouteSubcutaneous implant in the inner upper arm
FrequencyReplace every 12 months
DurationAnnual replacement while treatment remains indicated
PreparationSterile 50 mg implant supplied for insertion by a trained healthcare professional; not reconstituted.
Source: Dosage and Administration section 2; Dosage Forms and Strengths section 3

Working with a vial? The reconstitution calculator covers mixing math, not dosing advice.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalFDA-approved product exists
CompoundingFDA-approved product exists; compounded copies are not FDA approved

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.